. . . . "\uB958\uD504\uB85C\uB810\uB9B0(Leuprorelin, \uC0C1\uD45C\uBA85: \uB8E8\uD504\uB860)\uC740 \uC804\uB9BD\uC120\uC554, \uC720\uBC29\uC554, \uC790\uAD81\uB0B4\uB9C9\uC99D, \uC790\uAD81\uADFC\uC885, \uC131\uC870\uC219\uC99D \uB4F1\uC5D0 \uC4F0\uC774\uB294 \uC57D\uBB3C\uC774\uB2E4. \uD754\uD55C \uBD80\uC791\uC6A9\uC73C\uB85C\uB294 , \uAE30\uBD84 \uBCC0\uD654, \uBD88\uBA74 \uC99D\uC0C1, \uB450\uD1B5 \uB4F1\uC774 \uC788\uC73C\uBA70, \uACE0\uD608\uB2F9, \uC54C\uB7EC\uC9C0 \uBC18\uC751, \uB1CC\uD558\uC218\uCCB4 \uACBD\uC0C9 \uB4F1\uC758 \uC2DC\uC0C1\uD558\uBD80 \uBC0F \uB1CC\uD558\uC218\uCCB4 \uC0C1\uD0DC\uBCC0\uD654 \uB4F1\uC774 \uC788\uB2E4. \uC784\uC2E0 \uC911 \uB958\uD504\uB85C\uB810\uB9B0 \uC0AC\uC6A9\uC740 \uD0DC\uC544\uC5D0\uAC8C \uC704\uD574\uB97C \uAC00\uD560 \uC218 \uC788\uB2E4. \uB958\uD504\uB85C\uB810\uB9B0\uC740 \uC5D0 \uC18D\uD558\uBA70, \uB1CC\uD558\uC218\uCCB4\uC758 \uC5D0\uC11C GnRH \uC791\uC6A9\uC81C \uBC0F \uC73C\uB85C \uC791\uC6A9\uD558\uC5EC \uC131\uC120\uC790\uADF9\uD638\uB974\uBAAC\uC744 \uAC10\uC18C\uC2DC\uD0A4\uACE0 \uACB0\uACFC\uC801\uC73C\uB85C \uD14C\uC2A4\uD1A0\uC2A4\uD14C\uB860 \uBC0F \uC5D0\uC2A4\uD2B8\uB77C\uB514\uC62C \uBD84\uBE44\uB97C \uC904\uC778\uB2E4."@ko . . "leuprolide, leuprolidine, A-43818, Abbott-43818, DC-2-269, TAP-144"@en . . . . . . . . . . . "84"^^ . "\u041B\u0435\u0439\u043F\u0440\u043E\u0440\u0435\u043B\u0456\u043D (\u0430\u043D\u0433\u043B. Leuprorelin, \u043B\u0430\u0442. Leuprorelinum) \u2014 \u0441\u0438\u043D\u0442\u0435\u0442\u0438\u0447\u043D\u0438\u0439 \u043B\u0456\u043A\u0430\u0440\u0441\u044C\u043A\u0438\u0439 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442, \u044F\u043A\u0438\u0439 \u0437\u0430 \u0441\u0432\u043E\u0454\u044E \u0445\u0456\u043C\u0456\u0447\u043D\u043E\u044E \u0431\u0443\u0434\u043E\u0432\u043E\u044E \u0454 \u043F\u043E\u043B\u0456\u043F\u0435\u043F\u0442\u0438\u0434\u043E\u043C \u0442\u0430 \u0430\u043D\u0430\u043B\u043E\u0433\u043E\u043C \u0433\u043E\u043D\u0430\u0434\u043E\u0442\u0440\u043E\u043F\u0456\u043D-\u0440\u0438\u043B\u0456\u0437\u0438\u043D\u0433 \u0433\u043E\u0440\u043C\u043E\u043D\u0443, \u0442\u0430 \u0437\u0430\u0441\u0442\u043E\u0441\u043E\u0432\u0443\u0454\u0442\u044C\u0441\u044F\u0432\u043D\u0443\u0442\u0440\u0456\u0448\u043D\u044C\u043E\u043C'\u044F\u0437\u043E\u0432\u043E \u0456 \u043F\u0456\u0434\u0448\u043A\u0456\u0440\u043D\u043E. \u041B\u0435\u0439\u043F\u0440\u043E\u0440\u0435\u043B\u0456\u043D \u0437\u0430\u0441\u0442\u043E\u0441\u043E\u0432\u0443\u0454\u0442\u044C\u0441\u044F \u0443 \u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0456\u0439 \u043F\u0440\u0430\u043A\u0442\u0438\u0446\u0456 \u0437 1984 \u0440\u043E\u043A\u0443."@uk . . . "Leuprorelin, also known as leuprolide, is a manufactured version of a hormone used to treat prostate cancer, breast cancer, endometriosis, uterine fibroids, and early puberty, to perform chemical castration of violent sex offenders, or as part of transgender hormone therapy. It is given by injection into a muscle or under the skin. Leuprorelin was patented in 1973 and approved for medical use in the United States in 1985. It is on the World Health Organization's List of Essential Medicines. It is sold under the brand name Lupron among others."@en . . . . . "\u041B\u0435\u0439\u043F\u0440\u043E\u0440\u0435\u043B\u0456\u043D (\u0430\u043D\u0433\u043B. Leuprorelin, \u043B\u0430\u0442. Leuprorelinum) \u2014 \u0441\u0438\u043D\u0442\u0435\u0442\u0438\u0447\u043D\u0438\u0439 \u043B\u0456\u043A\u0430\u0440\u0441\u044C\u043A\u0438\u0439 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442, \u044F\u043A\u0438\u0439 \u0437\u0430 \u0441\u0432\u043E\u0454\u044E \u0445\u0456\u043C\u0456\u0447\u043D\u043E\u044E \u0431\u0443\u0434\u043E\u0432\u043E\u044E \u0454 \u043F\u043E\u043B\u0456\u043F\u0435\u043F\u0442\u0438\u0434\u043E\u043C \u0442\u0430 \u0430\u043D\u0430\u043B\u043E\u0433\u043E\u043C \u0433\u043E\u043D\u0430\u0434\u043E\u0442\u0440\u043E\u043F\u0456\u043D-\u0440\u0438\u043B\u0456\u0437\u0438\u043D\u0433 \u0433\u043E\u0440\u043C\u043E\u043D\u0443, \u0442\u0430 \u0437\u0430\u0441\u0442\u043E\u0441\u043E\u0432\u0443\u0454\u0442\u044C\u0441\u044F\u0432\u043D\u0443\u0442\u0440\u0456\u0448\u043D\u044C\u043E\u043C'\u044F\u0437\u043E\u0432\u043E \u0456 \u043F\u0456\u0434\u0448\u043A\u0456\u0440\u043D\u043E. \u041B\u0435\u0439\u043F\u0440\u043E\u0440\u0435\u043B\u0456\u043D \u0437\u0430\u0441\u0442\u043E\u0441\u043E\u0432\u0443\u0454\u0442\u044C\u0441\u044F \u0443 \u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0456\u0439 \u043F\u0440\u0430\u043A\u0442\u0438\u0446\u0456 \u0437 1984 \u0440\u043E\u043A\u0443."@uk . . . . . . . "657181" . . . . "Leuprorelina (\u0142ac. leuprorelinum) \u2013 wielofunkcyjny organiczny zwi\u0105zek chemiczny, nonapeptyd, syntetyczny analog gonadoliberyny, stosowany w leczeniu raka gruczo\u0142u krokowego, endometriozy, mi\u0119\u015Bniak\u00F3w macicy, przedwczesnego pokwitania oraz transseksualizmu."@pl . "(acetate)" . . . . . . "657181"^^ . . "[2-pyrrolidin-1-yl]-1-oxo-pentan-2-"@en . . . . "Lupron, Eligard, Lucrin, others"@en . . . . . "\u30EA\u30E5\u30FC\u30D7\u30ED\u30EC\u30EA\u30F3\uFF08Leuprorelin \u307E\u305F\u306F Leuprolide\u306FGnRH\u30A2\u30CA\u30ED\u30B0\u3067\u3042\u308B\u30DA\u30D7\u30C1\u30C9\u306E\u4E00\u3064\u3002\u30A2\u30DF\u30CE\u9178\u914D\u5217\u306F\u3001Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt\uFF08Pyr = \u30D4\u30ED\u30B0\u30EB\u30BF\u30DF\u30F3\u9178\uFF09\u3067\u3042\u308B\u3002\uFF09\u5546\u54C1\u540D\u30EA\u30E5\u30FC\u30D7\u30EA\u30F3\u3002"@ja . . "D"@en . "DB00007" . "Le\u016Dprorelino"@eo . . . . . . . . . . . . . "GFIJNRVAKGFPGQ-LIJARHBVSA-N"@en . "Le\u016Dprorelino estas fabrikita hormono, uzata por kuraci prostatan kanceron, maman kanceron, endometriozon, kaj . \u011Ci estas injektita enmuskole a\u016D subha\u016Dte. Oftaj kromefikoj estas , nestabila humoro, dormaj problemoj, kapdoloroj, kaj doloro \u0109e la injekta loko. Anka\u016D povas okazi osta perdo, grava deprimo, eterna artikodama\u011Do, kario, kaj perdo de dentoj. Aliaj kromefikoj inkludas troan sangosukeron, alergiajn reagojn, kaj hipofizaj problemoj. Uzo dum gravedeco povas dama\u011Di la bebon."@eo . "571356"^^ . . "a685040" . "La leuprorelina, tambi\u00E9n conocida como leuprolida, es una versi\u00F3n fabricada (sint\u00E9tica) de una hormona que se usa para tratar el c\u00E1ncer de pr\u00F3stata, el c\u00E1ncer de mama, la endometriosis, los fibromas uterinos y la pubertad temprana, o como parte de la terapia hormonal para las personas transg\u00E9nero. Se administra mediante una inyecci\u00F3n en un m\u00FAsculo o debajo de la piel.\u200B\u200B\u200B Los efectos secundarios comunes incluyen sofocos, estado de \u00E1nimo inestable, dificultad para dormir, dolores de cabeza y dolor en el lugar de la inyecci\u00F3n. Otros efectos secundarios pueden incluir niveles altos de az\u00FAcar en sangre, reacciones al\u00E9rgicas y problemas con la gl\u00E1ndula pituitaria . El uso durante el embarazo puede da\u00F1ar al beb\u00E9. La leuprorelina pertenece a la familia de medicamentos an\u00E1logos de la hormona liberadora de gonadotropina (GnRH). Act\u00FAa disminuyendo la gonadotropina y, por lo tanto, disminuyendo la testosterona y el estradiol.\u200B La leuprorelina fue descubierta y patentada por primera vez en 1973 y se introdujo para uso m\u00E9dico en los Estados Unidos en 1985. Inicialmente se comercializ\u00F3 solo para inyecci\u00F3n diaria, pero en 1989 se introdujo una formulaci\u00F3n de inyecci\u00F3n de dep\u00F3sito. \u200B\u200B Est\u00E1 en la Lista de medicamentos esenciales de la Organizaci\u00F3n Mundial de la Salud.\u200B"@es . . . . . . . . "\u041B\u0435\u0439\u043F\u0440\u043E\u0440\u0435\u043B\u0456\u043D"@uk . . . "pyrrolidine-2-carboxamide"@en . . . "EFY6W0M8TG"@en . . . . . . . . . . "250"^^ . "changed"@en . "Rx-only"@en . "Leuprorelin, juga disebut sebagai leuprolida, adalah sebuah versi yang diproduksi pabrik dari hormon yang dipakai untuk mengobati kanker prostat, kanker payudara, dan . Obat tersebut diberikan lewat penyuntikan ke otot atau bagian dalam kulit."@in . . . "Leuprorelin, also known as leuprolide, is a manufactured version of a hormone used to treat prostate cancer, breast cancer, endometriosis, uterine fibroids, and early puberty, to perform chemical castration of violent sex offenders, or as part of transgender hormone therapy. It is given by injection into a muscle or under the skin. Leuprorelin is in the gonadotropin-releasing hormone (GnRH) analogue family of medications. It works by decreasing gonadotropin and therefore decreasing testosterone and estradiol. Common side effects include hot flashes, unstable mood, trouble sleeping, headaches, and pain at the site of injection. Other side effects may include high blood sugar, allergic reactions, and problems with the pituitary gland. Use during pregnancy may harm the baby. Leuprorelin was patented in 1973 and approved for medical use in the United States in 1985. It is on the World Health Organization's List of Essential Medicines. It is sold under the brand name Lupron among others."@en . "Rx-only"@en . "Lupron, Eligard, Lucrin, others"@en . . "53714-56-0" . . . . . "\u30EA\u30E5\u30FC\u30D7\u30ED\u30EC\u30EA\u30F3"@ja . . . "Leuprorelina acetato (DCI) o leuprolide \u00E8 un farmaco non steroideo antiandrogeno, agonista dell'ormone di rilascio delle gonadotropine (GnRH). Leuprorelina \u00E8 stata brevettata nel 1973 e approvata per uso medico negli Stati Uniti nel 1985 . \u00C8 inclusa nell'elenco dei farmaci essenziali secondo l'Organizzazione Mondiale della Sanit\u00E0, i farmaci pi\u00F9 efficaci e sicuri necessari in un sistema sanitario . Nel Regno Unito una dose mensile costa al SSN circa \u00A3 75,24 . Negli Stati Uniti la dose equivalente ha un costo all'ingrosso di 1.011,93 USD ."@it . "1175"^^ . . . "\u0644\u064A\u0648\u0628\u0631\u0648\u0631\u0644\u064A\u0646 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629 leuprorelin) \u0648\u064A\u0639\u0631\u0641 \u0623\u064A\u0636\u0627 \u0628 (\u0644\u064A\u0648\u0628\u0631\u0648\u0644\u0627\u064A\u062F) , \u0647\u0648 \u0646\u0633\u062E\u0629 \u0645\u0635\u0646\u0639\u0629 \u0645\u0646 \u0647\u0631\u0645\u0648\u0646 \u064A\u0633\u062A\u062E\u062F\u0645 \u0644\u0639\u0644\u0627\u062C \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0628\u0631\u0648\u0633\u062A\u0627\u062A\u0627\u060C \u0648\u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u062B\u062F\u064A\u060C \u0628\u0637\u0627\u0646\u0629 \u0627\u0644\u0631\u062D\u0645\u060C \u0627\u0644\u0623\u0648\u0631\u0627\u0645 \u0627\u0644\u0644\u064A\u0641\u064A\u0629 \u0627\u0644\u0631\u062D\u0645\u064A\u0629\u060C \u0648\u0627\u0644\u0628\u0644\u0648\u063A \u0627\u0644\u0645\u0628\u0643\u0631. \u0648\u064A\u0639\u0637\u0649 \u0639\u0646 \u0637\u0631\u064A\u0642 \u0627\u0644\u062D\u0642\u0646 \u0641\u064A \u0627\u0644\u0639\u0636\u0644\u0627\u062A \u0623\u0648 \u062A\u062D\u062A \u0627\u0644\u062C\u0644\u062F. \u0627\u0644\u0622\u062B\u0627\u0631 \u0627\u0644\u062C\u0627\u0646\u0628\u064A\u0629 \u0627\u0644\u0634\u0627\u0626\u0639\u0629 \u062A\u0634\u0645\u0644 \u0648\u0645\u0636\u0627\u062A \u0633\u0627\u062E\u0646\u0629\u060C \u0648\u0627\u0644\u0645\u0632\u0627\u062C \u063A\u064A\u0631 \u0627\u0644\u0645\u0633\u062A\u0642\u0631\u060C \u0645\u0634\u0627\u0643\u0644 \u0641\u064A \u0627\u0644\u0646\u0648\u0645\u060C \u0648\u0627\u0644\u0635\u062F\u0627\u0639\u060C \u0648\u0627\u0644\u0623\u0644\u0645 \u0641\u064A \u0645\u0643\u0627\u0646 \u0627\u0644\u062D\u0642\u0646\u060C \u0627\u0644\u0622\u062B\u0627\u0631 \u0627\u0644\u062C\u0627\u0646\u0628\u064A\u0629 \u0627\u0644\u0623\u062E\u0631\u0649 \u0642\u062F \u062A\u0634\u0645\u0644 \u0627\u0631\u062A\u0641\u0627\u0639 \u0646\u0633\u0628\u0629 \u0627\u0644\u0633\u0643\u0631 \u0641\u064A \u0627\u0644\u062F\u0645\u060C \u0627\u0644\u062D\u0633\u0627\u0633\u064A\u0629\u060C \u0648\u0645\u0634\u0627\u0643\u0644 \u0641\u064A \u0627\u0644\u063A\u062F\u0629 \u0627\u0644\u0646\u062E\u0627\u0645\u064A\u0629. \u0627\u0633\u062A\u062E\u062F\u0627\u0645\u0647 \u0623\u062B\u0646\u0627\u0621 \u0627\u0644\u062D\u0645\u0644 \u0642\u062F \u064A\u0636\u0631 \u0627\u0644\u0637\u0641\u0644. \u0648\u0647\u0648 \u064A\u0639\u0645\u0644 \u0639\u0646 \u0637\u0631\u064A\u0642 \u062E\u0641\u0636 \u0648\u0638\u064A\u0641\u0629 \u0627\u0644\u063A\u062F\u062F \u0627\u0644\u062A\u0646\u0627\u0633\u0644\u064A\u0629 \u0648\u0628\u0627\u0644\u062A\u0627\u0644\u064A \u062A\u0642\u0644\u064A\u0644 \u0627\u0644\u062A\u0633\u062A\u0648\u0633\u062A\u064A\u0631\u0648\u0646 \u0648\u0627\u0633\u062A\u0631\u0627\u062F\u064A\u0648\u0644."@ar . . "\u0644\u064A\u0648\u0628\u0631\u0648\u0631\u0644\u064A\u0646"@ar . . "Leuprorelina acetato (DCI) o leuprolide \u00E8 un farmaco non steroideo antiandrogeno, agonista dell'ormone di rilascio delle gonadotropine (GnRH). Leuprorelina \u00E8 stata brevettata nel 1973 e approvata per uso medico negli Stati Uniti nel 1985 . \u00C8 inclusa nell'elenco dei farmaci essenziali secondo l'Organizzazione Mondiale della Sanit\u00E0, i farmaci pi\u00F9 efficaci e sicuri necessari in un sistema sanitario . Nel Regno Unito una dose mensile costa al SSN circa \u00A3 75,24 . Negli Stati Uniti la dose equivalente ha un costo all'ingrosso di 1.011,93 USD ."@it . . . "AE02"@en . . "Rx-only"@en . "DB00007"@en . . "carbamoyl]-2-hydroxy-ethyl]carbamoyl]-2-ethyl]carbamoyl]-2-ethyl]-5-oxo-"@en . . . . "a685040"@en . . "Leuprorelin"@en . . . "La leupror\u00E9line ou leuprolide est un nonapeptide de synth\u00E8se analogue de l\u2019hormone de lib\u00E9ration des gonadotrophines hypophysaires. L\u2019ac\u00E9tate de leupror\u00E9line est un sel d\u2019ac\u00E9tate obtenu en combinant de la leupror\u00E9line avec de l\u2019acide ac\u00E9tique. C\u2019est un m\u00E9dicament d\u2019hormonoth\u00E9rapie commercialis\u00E9 sous les noms Lupron et Eligard, et utilis\u00E9, en oncologie, dans le traitement du cancer de la prostate avanc\u00E9 ou comme hormonoth\u00E9rapie pour personnes transgenre ou en questionnement sur leur identit\u00E9 de genre. Il ralentit ou inhibe la production de testost\u00E9rone pour bloquer ou ralentir la croissance et la reproduction des cellules canc\u00E9reuses lors du traitement du cancer de la prostate. Dans le cas des personnes transgenre assign\u00E9e homme \u00E0 la naissance, bloque la testost\u00E9rone qui peut \u00EAtre source de"@fr . . . . . "1122452018"^^ . . . . "\uB958\uD504\uB85C\uB810\uB9B0(Leuprorelin, \uC0C1\uD45C\uBA85: \uB8E8\uD504\uB860)\uC740 \uC804\uB9BD\uC120\uC554, \uC720\uBC29\uC554, \uC790\uAD81\uB0B4\uB9C9\uC99D, \uC790\uAD81\uADFC\uC885, \uC131\uC870\uC219\uC99D \uB4F1\uC5D0 \uC4F0\uC774\uB294 \uC57D\uBB3C\uC774\uB2E4. \uD754\uD55C \uBD80\uC791\uC6A9\uC73C\uB85C\uB294 , \uAE30\uBD84 \uBCC0\uD654, \uBD88\uBA74 \uC99D\uC0C1, \uB450\uD1B5 \uB4F1\uC774 \uC788\uC73C\uBA70, \uACE0\uD608\uB2F9, \uC54C\uB7EC\uC9C0 \uBC18\uC751, \uB1CC\uD558\uC218\uCCB4 \uACBD\uC0C9 \uB4F1\uC758 \uC2DC\uC0C1\uD558\uBD80 \uBC0F \uB1CC\uD558\uC218\uCCB4 \uC0C1\uD0DC\uBCC0\uD654 \uB4F1\uC774 \uC788\uB2E4. \uC784\uC2E0 \uC911 \uB958\uD504\uB85C\uB810\uB9B0 \uC0AC\uC6A9\uC740 \uD0DC\uC544\uC5D0\uAC8C \uC704\uD574\uB97C \uAC00\uD560 \uC218 \uC788\uB2E4. \uB958\uD504\uB85C\uB810\uB9B0\uC740 \uC5D0 \uC18D\uD558\uBA70, \uB1CC\uD558\uC218\uCCB4\uC758 \uC5D0\uC11C GnRH \uC791\uC6A9\uC81C \uBC0F \uC73C\uB85C \uC791\uC6A9\uD558\uC5EC \uC131\uC120\uC790\uADF9\uD638\uB974\uBAAC\uC744 \uAC10\uC18C\uC2DC\uD0A4\uACE0 \uACB0\uACFC\uC801\uC73C\uB85C \uD14C\uC2A4\uD1A0\uC2A4\uD14C\uB860 \uBC0F \uC5D0\uC2A4\uD2B8\uB77C\uB514\uC62C \uBD84\uBE44\uB97C \uC904\uC778\uB2E4."@ko . . . "Leuprorelin ball-and-stick.png"@en . . . "411878260"^^ . . . . "Leuprorelin"@in . . . . "1201199" . . . . "butyl]carbamoyl]-2-ethyl]"@en . "16"^^ . "59"^^ . "\u30EA\u30E5\u30FC\u30D7\u30ED\u30EC\u30EA\u30F3\uFF08Leuprorelin \u307E\u305F\u306F Leuprolide\u306FGnRH\u30A2\u30CA\u30ED\u30B0\u3067\u3042\u308B\u30DA\u30D7\u30C1\u30C9\u306E\u4E00\u3064\u3002\u30A2\u30DF\u30CE\u9178\u914D\u5217\u306F\u3001Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt\uFF08Pyr = \u30D4\u30ED\u30B0\u30EB\u30BF\u30DF\u30F3\u9178\uFF09\u3067\u3042\u308B\u3002\uFF09\u5546\u54C1\u540D\u30EA\u30E5\u30FC\u30D7\u30EA\u30F3\u3002"@ja . "12"^^ . . "\u0397 \u03BB\u03B5\u03C5\u03C0\u03C1\u03BF\u03C1\u03B5\u03BB\u03AF\u03BD\u03B7, \u03B5\u03C0\u03AF\u03C3\u03B7\u03C2 \u03B3\u03BD\u03C9\u03C3\u03C4\u03AE \u03C9\u03C2 \u03BB\u03B5\u03C5\u03C0\u03C1\u03BF\u03BB\u03AF\u03B4\u03B7, \u03B5\u03AF\u03BD\u03B1\u03B9 \u03C3\u03C5\u03BD\u03B8\u03B5\u03C4\u03B9\u03BA\u03AE \u03B5\u03BA\u03B4\u03BF\u03C7\u03AE \u03BC\u03B9\u03B1\u03C2 \u03BF\u03C1\u03BC\u03CC\u03BD\u03B7\u03C2 \u03C0\u03BF\u03C5 \u03C7\u03C1\u03B7\u03C3\u03B9\u03BC\u03BF\u03C0\u03BF\u03B9\u03B5\u03AF\u03C4\u03B1\u03B9 \u03B3\u03B9\u03B1 \u03C4\u03B7 \u03B8\u03B5\u03C1\u03B1\u03C0\u03B5\u03AF\u03B1 \u03C4\u03BF\u03C5 \u03BA\u03B1\u03C1\u03BA\u03AF\u03BD\u03BF\u03C5 \u03C4\u03BF\u03C5 \u03C0\u03C1\u03BF\u03C3\u03C4\u03AC\u03C4\u03B7, \u03C4\u03BF\u03C5 \u03BA\u03B1\u03C1\u03BA\u03AF\u03BD\u03BF\u03C5 \u03C4\u03BF\u03C5 \u03BC\u03B1\u03C3\u03C4\u03BF\u03CD, \u03C4\u03B7\u03C2 \u03B5\u03BD\u03B4\u03BF\u03BC\u03B7\u03C4\u03C1\u03AF\u03C9\u03C3\u03B7\u03C2, \u03C4\u03C9\u03BD \u03B9\u03BD\u03BF\u03BC\u03C5\u03C9\u03BC\u03AC\u03C4\u03C9\u03BD \u03C4\u03B7\u03C2 \u03BC\u03AE\u03C4\u03C1\u03B1\u03C2 \u03BA\u03B1\u03B9 \u03C4\u03B7\u03C2 . \u03A7\u03BF\u03C1\u03B7\u03B3\u03B5\u03AF\u03C4\u03B1\u03B9 \u03BC\u03B5 \u03AD\u03BD\u03B5\u03C3\u03B7 \u03C3\u03B5 \u03BC\u03C5 \u03AE \u03BA\u03AC\u03C4\u03C9 \u03B1\u03C0\u03CC \u03C4\u03BF \u03B4\u03AD\u03C1\u03BC\u03B1. \u0397 \u03BB\u03B5\u03C5\u03C0\u03C1\u03BF\u03C1\u03B5\u03BB\u03AF\u03BD\u03B7 \u03BA\u03B1\u03C4\u03BF\u03C7\u03C5\u03C1\u03CE\u03B8\u03B7\u03BA\u03B5 \u03BC\u03B5 \u03B4\u03AF\u03C0\u03BB\u03C9\u03BC\u03B1 \u03B5\u03C5\u03C1\u03B5\u03C3\u03B9\u03C4\u03B5\u03C7\u03BD\u03AF\u03B1\u03C2 \u03C4\u03BF 1973 \u03BA\u03B1\u03B9 \u03B5\u03B3\u03BA\u03C1\u03AF\u03B8\u03B7\u03BA\u03B5 \u03B3\u03B9\u03B1 \u03B9\u03B1\u03C4\u03C1\u03B9\u03BA\u03AE \u03C7\u03C1\u03AE\u03C3\u03B7 \u03C3\u03C4\u03B9\u03C2 \u0397\u03BD\u03C9\u03BC\u03AD\u03BD\u03B5\u03C2 \u03A0\u03BF\u03BB\u03B9\u03C4\u03B5\u03AF\u03B5\u03C2 \u03C4\u03BF 1985. \u03A3\u03C5\u03BC\u03C0\u03B5\u03C1\u03B9\u03BB\u03B1\u03BC\u03B2\u03AC\u03BD\u03B5\u03C4\u03B1\u03B9 \u03C3\u03C4\u03BF\u03BD \u03BA\u03B1\u03C4\u03AC\u03BB\u03BF\u03B3\u03BF \u03B2\u03B1\u03C3\u03B9\u03BA\u03CE\u03BD \u03C6\u03B1\u03C1\u03BC\u03AC\u03BA\u03C9\u03BD \u03C4\u03BF\u03C5 \u03A0\u03B1\u03B3\u03BA\u03CC\u03C3\u03BC\u03B9\u03BF\u03C5 \u039F\u03C1\u03B3\u03B1\u03BD\u03B9\u03C3\u03BC\u03BF\u03CD \u03A5\u03B3\u03B5\u03AF\u03B1\u03C2. \u03A0\u03C9\u03BB\u03B5\u03AF\u03C4\u03B1\u03B9 \u03BC\u03B5 \u03C4\u03B7\u03BD \u03B5\u03BC\u03C0\u03BF\u03C1\u03B9\u03BA\u03AE \u03B5\u03C0\u03C9\u03BD\u03C5\u03BC\u03AF\u03B1 Lupron \u03BC\u03B5\u03C4\u03B1\u03BE\u03CD \u03AC\u03BB\u03BB\u03C9\u03BD."@el . . . . . . . "L02"@en . . . . "Leuprorelin ist ein GnRH-Analogon, das zu einem Stillstand der Hormonproduktion f\u00FChrt und zur k\u00FCnstlichen Absenkung des Testosteron- oder \u00D6strogen-Spiegels im Blut verwendet wird. Es ist ein Peptid, das aus neun Aminos\u00E4uren aufgebaut ist."@de . "53714"^^ . . "D08113" . . . . "Leuprolide"@en . . . . . . . . . . . . . . . . . . . . "Leuprorelina (\u0142ac. leuprorelinum) \u2013 wielofunkcyjny organiczny zwi\u0105zek chemiczny, nonapeptyd, syntetyczny analog gonadoliberyny, stosowany w leczeniu raka gruczo\u0142u krokowego, endometriozy, mi\u0119\u015Bniak\u00F3w macicy, przedwczesnego pokwitania oraz transseksualizmu."@pl . . "Leuprorelin ist ein GnRH-Analogon, das zu einem Stillstand der Hormonproduktion f\u00FChrt und zur k\u00FCnstlichen Absenkung des Testosteron- oder \u00D6strogen-Spiegels im Blut verwendet wird. Es ist ein Peptid, das aus neun Aminos\u00E4uren aufgebaut ist."@de . . "\u039B\u03B5\u03C5\u03C0\u03C1\u03BF\u03C1\u03B5\u03BB\u03AF\u03BD\u03B7"@el . . . "D08113"@en . . . . "1201199"^^ . "Leuprorelin, juga disebut sebagai leuprolida, adalah sebuah versi yang diproduksi pabrik dari hormon yang dipakai untuk mengobati kanker prostat, kanker payudara, dan . Obat tersebut diberikan lewat penyuntikan ke otot atau bagian dalam kulit."@in . . . . . . . . . . . . . . . . . "10800.0"^^ . . "yl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-"@en . "N-[1-[[1-[[1-[[1-[[1-[[1-[[5--1-"@en . . . "Le\u016Dprorelino estas fabrikita hormono, uzata por kuraci prostatan kanceron, maman kanceron, endometriozon, kaj . \u011Ci estas injektita enmuskole a\u016D subha\u016Dte. Oftaj kromefikoj estas , nestabila humoro, dormaj problemoj, kapdoloroj, kaj doloro \u0109e la injekta loko. Anka\u016D povas okazi osta perdo, grava deprimo, eterna artikodama\u011Do, kario, kaj perdo de dentoj. Aliaj kromefikoj inkludas troan sangosukeron, alergiajn reagojn, kaj hipofizaj problemoj. Uzo dum gravedeco povas dama\u011Di la bebon. Le\u016Dprorelino estas analoga\u0135o de gonadotropin-liberiga hormono. \u011Ci funkcias per malpliigo de gonadotropino kaj sekve testosterono kaj oestradiolo. \u011Ci estas listata de MOS kiel esenca medikamento."@eo . . . . . . . "1336519"^^ . . . . "45410"^^ . . . . . . . "EFY6W0M8TG" . "La leupror\u00E9line ou leuprolide est un nonapeptide de synth\u00E8se analogue de l\u2019hormone de lib\u00E9ration des gonadotrophines hypophysaires. L\u2019ac\u00E9tate de leupror\u00E9line est un sel d\u2019ac\u00E9tate obtenu en combinant de la leupror\u00E9line avec de l\u2019acide ac\u00E9tique. C\u2019est un m\u00E9dicament d\u2019hormonoth\u00E9rapie commercialis\u00E9 sous les noms Lupron et Eligard, et utilis\u00E9, en oncologie, dans le traitement du cancer de la prostate avanc\u00E9 ou comme hormonoth\u00E9rapie pour personnes transgenre ou en questionnement sur leur identit\u00E9 de genre. Il ralentit ou inhibe la production de testost\u00E9rone pour bloquer ou ralentir la croissance et la reproduction des cellules canc\u00E9reuses lors du traitement du cancer de la prostate. Dans le cas des personnes transgenre assign\u00E9e homme \u00E0 la naissance, bloque la testost\u00E9rone qui peut \u00EAtre source de dysphorie, particuli\u00E8rement pendant la pubert\u00E9 et laisse quelques mois, voir ann\u00E9es, de pause de la croissance du corps pour les personnes questionnant leur identit\u00E9 de genre. Il est administr\u00E9 par injection sous-cutan\u00E9e sous forme d'ac\u00E9tate de leupor\u00E9line."@fr . . . "Leuprorelina"@it . "\u0397 \u03BB\u03B5\u03C5\u03C0\u03C1\u03BF\u03C1\u03B5\u03BB\u03AF\u03BD\u03B7, \u03B5\u03C0\u03AF\u03C3\u03B7\u03C2 \u03B3\u03BD\u03C9\u03C3\u03C4\u03AE \u03C9\u03C2 \u03BB\u03B5\u03C5\u03C0\u03C1\u03BF\u03BB\u03AF\u03B4\u03B7, \u03B5\u03AF\u03BD\u03B1\u03B9 \u03C3\u03C5\u03BD\u03B8\u03B5\u03C4\u03B9\u03BA\u03AE \u03B5\u03BA\u03B4\u03BF\u03C7\u03AE \u03BC\u03B9\u03B1\u03C2 \u03BF\u03C1\u03BC\u03CC\u03BD\u03B7\u03C2 \u03C0\u03BF\u03C5 \u03C7\u03C1\u03B7\u03C3\u03B9\u03BC\u03BF\u03C0\u03BF\u03B9\u03B5\u03AF\u03C4\u03B1\u03B9 \u03B3\u03B9\u03B1 \u03C4\u03B7 \u03B8\u03B5\u03C1\u03B1\u03C0\u03B5\u03AF\u03B1 \u03C4\u03BF\u03C5 \u03BA\u03B1\u03C1\u03BA\u03AF\u03BD\u03BF\u03C5 \u03C4\u03BF\u03C5 \u03C0\u03C1\u03BF\u03C3\u03C4\u03AC\u03C4\u03B7, \u03C4\u03BF\u03C5 \u03BA\u03B1\u03C1\u03BA\u03AF\u03BD\u03BF\u03C5 \u03C4\u03BF\u03C5 \u03BC\u03B1\u03C3\u03C4\u03BF\u03CD, \u03C4\u03B7\u03C2 \u03B5\u03BD\u03B4\u03BF\u03BC\u03B7\u03C4\u03C1\u03AF\u03C9\u03C3\u03B7\u03C2, \u03C4\u03C9\u03BD \u03B9\u03BD\u03BF\u03BC\u03C5\u03C9\u03BC\u03AC\u03C4\u03C9\u03BD \u03C4\u03B7\u03C2 \u03BC\u03AE\u03C4\u03C1\u03B1\u03C2 \u03BA\u03B1\u03B9 \u03C4\u03B7\u03C2 . \u03A7\u03BF\u03C1\u03B7\u03B3\u03B5\u03AF\u03C4\u03B1\u03B9 \u03BC\u03B5 \u03AD\u03BD\u03B5\u03C3\u03B7 \u03C3\u03B5 \u03BC\u03C5 \u03AE \u03BA\u03AC\u03C4\u03C9 \u03B1\u03C0\u03CC \u03C4\u03BF \u03B4\u03AD\u03C1\u03BC\u03B1. \u03A3\u03C5\u03C7\u03BD\u03AD\u03C2 \u03B1\u03BD\u03B5\u03C0\u03B9\u03B8\u03CD\u03BC\u03B7\u03C4\u03B5\u03C2 \u03B5\u03BD\u03AD\u03C1\u03B3\u03B5\u03B9\u03B5\u03C2 \u03C0\u03B5\u03C1\u03B9\u03BB\u03B1\u03BC\u03B2\u03AC\u03BD\u03BF\u03C5\u03BD \u03B5\u03BE\u03AC\u03C8\u03B5\u03B9\u03C2, \u03B1\u03C3\u03C4\u03B1\u03B8\u03AE \u03B4\u03B9\u03AC\u03B8\u03B5\u03C3\u03B7, \u03C0\u03C1\u03BF\u03B2\u03BB\u03AE\u03BC\u03B1\u03C4\u03B1 \u03CD\u03C0\u03BD\u03BF\u03C5, \u03C0\u03BF\u03BD\u03BF\u03BA\u03B5\u03C6\u03AC\u03BB\u03BF\u03C5\u03C2 \u03BA\u03B1\u03B9 \u03C0\u03CC\u03BD\u03BF \u03C3\u03C4\u03BF \u03C3\u03B7\u03BC\u03B5\u03AF\u03BF \u03C4\u03B7\u03C2 \u03AD\u03BD\u03B5\u03C3\u03B7\u03C2. \u0386\u03BB\u03BB\u03B5\u03C2 \u03B1\u03BD\u03B5\u03C0\u03B9\u03B8\u03CD\u03BC\u03B7\u03C4\u03B5\u03C2 \u03B5\u03BD\u03AD\u03C1\u03B3\u03B5\u03B9\u03B5\u03C2 \u03BC\u03C0\u03BF\u03C1\u03B5\u03AF \u03BD\u03B1 \u03C0\u03B5\u03C1\u03B9\u03BB\u03B1\u03BC\u03B2\u03AC\u03BD\u03BF\u03C5\u03BD \u03C5\u03C8\u03B7\u03BB\u03CC \u03C3\u03AC\u03BA\u03C7\u03B1\u03C1\u03BF \u03C3\u03C4\u03BF \u03B1\u03AF\u03BC\u03B1, \u03B1\u03BB\u03BB\u03B5\u03C1\u03B3\u03B9\u03BA\u03AD\u03C2 \u03B1\u03BD\u03C4\u03B9\u03B4\u03C1\u03AC\u03C3\u03B5\u03B9\u03C2 \u03BA\u03B1\u03B9 \u03C0\u03C1\u03BF\u03B2\u03BB\u03AE\u03BC\u03B1\u03C4\u03B1 \u03BC\u03B5 \u03C4\u03B7\u03BD \u03C5\u03C0\u03CC\u03C6\u03C5\u03C3\u03B7. \u0397 \u03C7\u03C1\u03AE\u03C3\u03B7 \u03BA\u03B1\u03C4\u03AC \u03C4\u03B7 \u03B4\u03B9\u03AC\u03C1\u03BA\u03B5\u03B9\u03B1 \u03C4\u03B7\u03C2 \u03B5\u03B3\u03BA\u03C5\u03BC\u03BF\u03C3\u03CD\u03BD\u03B7\u03C2 \u03BC\u03C0\u03BF\u03C1\u03B5\u03AF \u03BD\u03B1 \u03B2\u03BB\u03AC\u03C8\u03B5\u03B9 \u03C4\u03BF \u03BC\u03C9\u03C1\u03CC. \u0397 \u03BB\u03B5\u03C5\u03C0\u03C1\u03BF\u03C1\u03B5\u03BB\u03AF\u03BD\u03B7 \u03B1\u03BD\u03AE\u03BA\u03B5\u03B9 \u03C3\u03C4\u03B7\u03BD \u03BF\u03B9\u03BA\u03BF\u03B3\u03AD\u03BD\u03B5\u03B9\u03B1 \u03C6\u03B1\u03C1\u03BC\u03AC\u03BA\u03C9\u03BD \u03B1\u03BD\u03AC\u03BB\u03BF\u03B3\u03B1 \u03C4\u03B7\u03C2 \u03BF\u03C1\u03BC\u03CC\u03BD\u03B7\u03C2 \u03B1\u03C0\u03B5\u03BB\u03B5\u03C5\u03B8\u03AD\u03C1\u03C9\u03C3\u03B7\u03C2 \u03B3\u03BF\u03BD\u03B1\u03B4\u03BF\u03C4\u03C1\u03BF\u03C0\u03AF\u03BD\u03B7\u03C2 (GnRH). \u039B\u03B5\u03B9\u03C4\u03BF\u03C5\u03C1\u03B3\u03B5\u03AF \u03BC\u03B5\u03B9\u03CE\u03BD\u03BF\u03BD\u03C4\u03B1\u03C2 \u03C4\u03B7 \u03B3\u03BF\u03BD\u03B1\u03B4\u03BF\u03C4\u03C1\u03BF\u03C0\u03AF\u03BD\u03B7 \u03BA\u03B1\u03B9 \u03B5\u03C0\u03BF\u03BC\u03AD\u03BD\u03C9\u03C2 \u03BC\u03B5\u03B9\u03CE\u03BD\u03BF\u03BD\u03C4\u03B1\u03C2 \u03C4\u03B7\u03BD \u03C4\u03B5\u03C3\u03C4\u03BF\u03C3\u03C4\u03B5\u03C1\u03CC\u03BD\u03B7 \u03BA\u03B1\u03B9 \u03C4\u03B7\u03BD \u03BF\u03B9\u03C3\u03C4\u03C1\u03B1\u03B4\u03B9\u03CC\u03BB\u03B7. \u0397 \u03BB\u03B5\u03C5\u03C0\u03C1\u03BF\u03C1\u03B5\u03BB\u03AF\u03BD\u03B7 \u03BA\u03B1\u03C4\u03BF\u03C7\u03C5\u03C1\u03CE\u03B8\u03B7\u03BA\u03B5 \u03BC\u03B5 \u03B4\u03AF\u03C0\u03BB\u03C9\u03BC\u03B1 \u03B5\u03C5\u03C1\u03B5\u03C3\u03B9\u03C4\u03B5\u03C7\u03BD\u03AF\u03B1\u03C2 \u03C4\u03BF 1973 \u03BA\u03B1\u03B9 \u03B5\u03B3\u03BA\u03C1\u03AF\u03B8\u03B7\u03BA\u03B5 \u03B3\u03B9\u03B1 \u03B9\u03B1\u03C4\u03C1\u03B9\u03BA\u03AE \u03C7\u03C1\u03AE\u03C3\u03B7 \u03C3\u03C4\u03B9\u03C2 \u0397\u03BD\u03C9\u03BC\u03AD\u03BD\u03B5\u03C2 \u03A0\u03BF\u03BB\u03B9\u03C4\u03B5\u03AF\u03B5\u03C2 \u03C4\u03BF 1985. \u03A3\u03C5\u03BC\u03C0\u03B5\u03C1\u03B9\u03BB\u03B1\u03BC\u03B2\u03AC\u03BD\u03B5\u03C4\u03B1\u03B9 \u03C3\u03C4\u03BF\u03BD \u03BA\u03B1\u03C4\u03AC\u03BB\u03BF\u03B3\u03BF \u03B2\u03B1\u03C3\u03B9\u03BA\u03CE\u03BD \u03C6\u03B1\u03C1\u03BC\u03AC\u03BA\u03C9\u03BD \u03C4\u03BF\u03C5 \u03A0\u03B1\u03B3\u03BA\u03CC\u03C3\u03BC\u03B9\u03BF\u03C5 \u039F\u03C1\u03B3\u03B1\u03BD\u03B9\u03C3\u03BC\u03BF\u03CD \u03A5\u03B3\u03B5\u03AF\u03B1\u03C2. \u03A0\u03C9\u03BB\u03B5\u03AF\u03C4\u03B1\u03B9 \u03BC\u03B5 \u03C4\u03B7\u03BD \u03B5\u03BC\u03C0\u03BF\u03C1\u03B9\u03BA\u03AE \u03B5\u03C0\u03C9\u03BD\u03C5\u03BC\u03AF\u03B1 Lupron \u03BC\u03B5\u03C4\u03B1\u03BE\u03CD \u03AC\u03BB\u03BB\u03C9\u03BD."@el . . . . . "Leupror\u00E9line"@fr . "Leuprorelina"@pl . "\uB958\uD504\uB85C\uB810\uB9B0"@ko . . . "1"^^ . . "La leuprorelina, tambi\u00E9n conocida como leuprolida, es una versi\u00F3n fabricada (sint\u00E9tica) de una hormona que se usa para tratar el c\u00E1ncer de pr\u00F3stata, el c\u00E1ncer de mama, la endometriosis, los fibromas uterinos y la pubertad temprana, o como parte de la terapia hormonal para las personas transg\u00E9nero. Se administra mediante una inyecci\u00F3n en un m\u00FAsculo o debajo de la piel.\u200B\u200B\u200B Est\u00E1 en la Lista de medicamentos esenciales de la Organizaci\u00F3n Mundial de la Salud.\u200B"@es . "changed"@en . . . . "CCNC[C@@H]1CCCN1C[C@H]NC[C@H]NC[C@@H]NC[C@H]NC[C@H]NC[C@H]NC[C@H]NC[C@@H]6CCCN6"@en . "Leuprorelin"@de . "Leuprorelin"@es . . . . . "\u0644\u064A\u0648\u0628\u0631\u0648\u0631\u0644\u064A\u0646 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629 leuprorelin) \u0648\u064A\u0639\u0631\u0641 \u0623\u064A\u0636\u0627 \u0628 (\u0644\u064A\u0648\u0628\u0631\u0648\u0644\u0627\u064A\u062F) , \u0647\u0648 \u0646\u0633\u062E\u0629 \u0645\u0635\u0646\u0639\u0629 \u0645\u0646 \u0647\u0631\u0645\u0648\u0646 \u064A\u0633\u062A\u062E\u062F\u0645 \u0644\u0639\u0644\u0627\u062C \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0628\u0631\u0648\u0633\u062A\u0627\u062A\u0627\u060C \u0648\u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u062B\u062F\u064A\u060C \u0628\u0637\u0627\u0646\u0629 \u0627\u0644\u0631\u062D\u0645\u060C \u0627\u0644\u0623\u0648\u0631\u0627\u0645 \u0627\u0644\u0644\u064A\u0641\u064A\u0629 \u0627\u0644\u0631\u062D\u0645\u064A\u0629\u060C \u0648\u0627\u0644\u0628\u0644\u0648\u063A \u0627\u0644\u0645\u0628\u0643\u0631. \u0648\u064A\u0639\u0637\u0649 \u0639\u0646 \u0637\u0631\u064A\u0642 \u0627\u0644\u062D\u0642\u0646 \u0641\u064A \u0627\u0644\u0639\u0636\u0644\u0627\u062A \u0623\u0648 \u062A\u062D\u062A \u0627\u0644\u062C\u0644\u062F. \u0627\u0644\u0622\u062B\u0627\u0631 \u0627\u0644\u062C\u0627\u0646\u0628\u064A\u0629 \u0627\u0644\u0634\u0627\u0626\u0639\u0629 \u062A\u0634\u0645\u0644 \u0648\u0645\u0636\u0627\u062A \u0633\u0627\u062E\u0646\u0629\u060C \u0648\u0627\u0644\u0645\u0632\u0627\u062C \u063A\u064A\u0631 \u0627\u0644\u0645\u0633\u062A\u0642\u0631\u060C \u0645\u0634\u0627\u0643\u0644 \u0641\u064A \u0627\u0644\u0646\u0648\u0645\u060C \u0648\u0627\u0644\u0635\u062F\u0627\u0639\u060C \u0648\u0627\u0644\u0623\u0644\u0645 \u0641\u064A \u0645\u0643\u0627\u0646 \u0627\u0644\u062D\u0642\u0646\u060C \u0627\u0644\u0622\u062B\u0627\u0631 \u0627\u0644\u062C\u0627\u0646\u0628\u064A\u0629 \u0627\u0644\u0623\u062E\u0631\u0649 \u0642\u062F \u062A\u0634\u0645\u0644 \u0627\u0631\u062A\u0641\u0627\u0639 \u0646\u0633\u0628\u0629 \u0627\u0644\u0633\u0643\u0631 \u0641\u064A \u0627\u0644\u062F\u0645\u060C \u0627\u0644\u062D\u0633\u0627\u0633\u064A\u0629\u060C \u0648\u0645\u0634\u0627\u0643\u0644 \u0641\u064A \u0627\u0644\u063A\u062F\u0629 \u0627\u0644\u0646\u062E\u0627\u0645\u064A\u0629. \u0627\u0633\u062A\u062E\u062F\u0627\u0645\u0647 \u0623\u062B\u0646\u0627\u0621 \u0627\u0644\u062D\u0645\u0644 \u0642\u062F \u064A\u0636\u0631 \u0627\u0644\u0637\u0641\u0644. \u0648\u0647\u0648 \u064A\u0639\u0645\u0644 \u0639\u0646 \u0637\u0631\u064A\u0642 \u062E\u0641\u0636 \u0648\u0638\u064A\u0641\u0629 \u0627\u0644\u063A\u062F\u062F \u0627\u0644\u062A\u0646\u0627\u0633\u0644\u064A\u0629 \u0648\u0628\u0627\u0644\u062A\u0627\u0644\u064A \u062A\u0642\u0644\u064A\u0644 \u0627\u0644\u062A\u0633\u062A\u0648\u0633\u062A\u064A\u0631\u0648\u0646 \u0648\u0627\u0633\u062A\u0631\u0627\u062F\u064A\u0648\u0644. \u062A\u0645\u062A \u0627\u0644\u0645\u0648\u0627\u0641\u0642\u0629 \u0639\u0644\u0649 \u0644\u064A\u0648\u0628\u0631\u0648\u0631\u064A\u0644\u064A\u0646 \u0644\u0644\u0627\u0633\u062A\u062E\u062F\u0627\u0645 \u0627\u0644\u0637\u0628\u0649 \u0641\u064A \u0627\u0644\u0648\u0644\u0627\u064A\u0627\u062A \u0627\u0644\u0645\u062A\u062D\u062F\u0629 \u0641\u064A \u0639\u0627\u0645 1985, \u0648\u0647\u0648 \u0645\u062F\u0631\u062C \u0641\u064A \u0642\u0627\u0626\u0645\u0629 \u0627\u0644\u0623\u062F\u0648\u064A\u0629 \u0627\u0644\u0623\u0633\u0627\u0633\u064A\u0629 \u0644\u0645\u0646\u0638\u0645\u0629 \u0627\u0644\u0635\u062D\u0629 \u0627\u0644\u0639\u0627\u0644\u0645\u064A\u0629\u060C \u0648\u0647\u064A \u0627\u0644\u0623\u062F\u0648\u064A\u0629 \u0627\u0644\u0623\u0643\u062B\u0631 \u0641\u0639\u0627\u0644\u064A\u0629 \u0648\u0623\u0645\u0627\u0646\u0627 \u0627\u0644\u0644\u0627\u0632\u0645\u0629 \u0641\u064A \u0627\u0644\u0646\u0638\u0627\u0645 \u0627\u0644\u0635\u062D\u064A. \u0641\u064A \u0627\u0644\u0645\u0645\u0644\u0643\u0629 \u0627\u0644\u0645\u062A\u062D\u062F\u0629 \u0627\u0644\u062C\u0631\u0639\u0629 \u0627\u0644\u0634\u0647\u0631\u064A\u0629 \u062A\u0643\u0644\u0641 NHS \u062D\u0648\u0627\u0644\u064A 75.24 \u062C\u0646\u064A\u0647. \u0641\u064A \u0627\u0644\u0648\u0644\u0627\u064A\u0627\u062A \u0627\u0644\u0645\u062A\u062D\u062F\u0629 \u062A\u0643\u0644\u0641\u0629 \u0627\u0644\u062C\u0631\u0639\u0629 \u0627\u0644\u0645\u0643\u0627\u0641\u0626\u0629 \u0644\u062F\u064A\u0647\u0627 1011.93 \u062F\u0648\u0644\u0627\u0631 \u0623\u0645\u0631\u064A\u0643\u064A. \u064A\u0628\u0627\u0639 \u062A\u062D\u062A \u0627\u0633\u0645 \u0627\u0644\u0639\u0644\u0627\u0645\u0629 \u0627\u0644\u062A\u062C\u0627\u0631\u064A\u0629 \u0644\u0648\u0628\u0631\u0648\u0646."@ar .